Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biophytis Sa ADR (BPTS)

Biophytis Sa ADR (BPTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise FinancialNewsMedia - Tue Sep 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

BMY : 52.50 (-0.27%)
ONCY : 1.1900 (-2.46%)
ONC.TO : 1.64 (-3.53%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.5603 (-6.15%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONC.TO : 1.64 (-3.53%)
ONCY : 1.1900 (-2.46%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.5603 (-6.15%)
BMY : 52.50 (-0.27%)
Author
Russell 2000 ETF Momentum Sparks Volatility In Small Caps MarketBeat - Tue Jul 18, 2023

The iShares Russell 2000 ETF (NYSE: IWM) impressive upward momentum has led to a volume, attention, and volatility surge in the small-cap market.

IWM : 221.74 (-0.32%)
BPTS : 8.22 (-15.28%)
GP : 1.0100 (-16.18%)
PWM : 0.9049 (-0.56%)
Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for €4 Million AccessWire - Thu Jun 30, 2022

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 30, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics...

BPTS : 8.22 (-15.28%)
Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress AccessWire - Mon Jun 27, 2022

PARIS, FRANCE and CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / June 27, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company...

BPTS : 8.22 (-15.28%)
Biophytis: Results of the Combined General Meeting on June 21, 2022 AccessWire - Wed Jun 22, 2022

All ordinary and extraordinary resolutions presented by the company have been adopted

BPTS : 8.22 (-15.28%)
Biophytis: Convening of Another Combined General Meeting at a Later Date AccessWire - Fri Jun 3, 2022

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 3, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on...

BPTS : 8.22 (-15.28%)
Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June AccessWire - Thu May 12, 2022

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 12, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on...

BPTS : 8.22 (-15.28%)
Biophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022 AccessWire - Tue Apr 19, 2022

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 19, 2022 / Biophytis SA ((NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused...

BPTS : 8.22 (-15.28%)
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives AccessWire - Thu Apr 7, 2022

- Success of Nasdaq IPO in February 2021 - €23.9M of available cash on December 31 2021 and new financing instruments for a total of €42M allowing financial visibility beyond mid 2023 - Strong growth...

BPTS : 8.22 (-15.28%)

Barchart Exclusives

2 Promising Growth Stocks to Buy and Hold for a Decade or Longer Barchart - 16 minutes ago
These two growth stocks could be great additions to a long-term buy-and-hold portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot